We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Plans to Issue Almost 100 New or Revised Draft Guidances in 2018
CDER Plans to Issue Almost 100 New or Revised Draft Guidances in 2018
CDER published an agenda of 98 upcoming draft guidances for the 2018 calendar year — including new recommendations for developing treatments for Alzheimer’s and amyotrophic lateral sclerosis.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor